Enovis (ENOV) Income from Continuing Operations (2010 - 2026)
Enovis (ENOV) reported Income from Continuing Operations of 8411000.0 for Q2 2026, up 84.87% year-over-year from 4549760.87 in Q2 2025, and up 98.38% quarter-over-quarter from 518803000.0 in Q4 2025.
Enovis (ENOV) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Enovis (ENOV) has 17 years of Income from Continuing Operations data on file, last reported at 8411000.0 in Q2 2026.
- Income from Continuing Operations for Q2 2026 came in at 8411000.0, up 84.87% year-over-year; the trailing twelve-month figure through Apr 2026 was 1134542000.0 (down 39.87% YoY), and the FY2025 annual result was 1181711000.0, down 42.82% from the prior year.
- Income from Continuing Operations improved to 8411000.0 in Q2 2026 per ENOV's latest filing, from 518803000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 120600000.0 in Q3 2022 and troughed at 703626000.0 in Q4 2024.
- A 5-year average of 124097470.59 and a median of 36455000.0 in 2025 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2024: Income from Continuing Operations jumped 386.39% in 2022, then tumbled 23034.35% in 2024.
- A 5-year view of Income from Continuing Operations shows it stood at 54840000.0 in 2022, then surged by 105.59% to 3068000.0 in 2023, then plunged by 23034.35% to 703626000.0 in 2024, then grew by 26.27% to 518803000.0 in 2025, then jumped by 98.38% to 8411000.0 in 2026.
- Business Quant data shows ENOV's Income from Continuing Operations at 8411000.0 in Q2 2026, 518803000.0 in Q4 2025, and 570873000.0 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.15 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 273.95 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 199.50 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 411.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 220.30 Mn |
| 10 | Enovis | 1.26 Bn | 1.23 Bn | 365.49 Mn | -8.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -8.41 Mn |
| Dec 31, 2025 | -518.80 Mn |
| Oct 3, 2025 | -570.87 Mn |
| Jul 4, 2025 | -36.46 Mn |
| Apr 4, 2025 | -55.58 Mn |
| Dec 31, 2024 | -703.63 Mn |
| Sep 27, 2024 | -33.51 Mn |
| Jun 28, 2024 | -18.44 Mn |
| Mar 29, 2024 | -71.84 Mn |
| Dec 31, 2023 | 3.07 Mn |
| Sep 29, 2023 | -19.45 Mn |
| Jun 30, 2023 | -14.61 Mn |
| Mar 31, 2023 | -22.85 Mn |
| Dec 31, 2022 | -54.84 Mn |
| Sep 30, 2022 | -65.95 Mn |
| Jul 1, 2022 | 120.60 Mn |
| Apr 1, 2022 | -38.09 Mn |
| Dec 31, 2021 | -14.75 Mn |
| Oct 1, 2021 | -13.58 Mn |
| Jul 2, 2021 | -42.11 Mn |